154 related articles for article (PubMed ID: 24269042)
1. Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location.
Hill MJ; Cooper JC; Levy G; Alford C; Richter KS; DeCherney AH; Katz CL; Levens ED; Wolff EF
Fertil Steril; 2014 Feb; 101(2):413-9. PubMed ID: 24269042
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.
Boots CE; Hill MJ; Feinberg EC; Lathi RB; Fowler SA; Jungheim ES
J Assist Reprod Genet; 2016 May; 33(5):647-656. PubMed ID: 26943917
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate treatment of ectopic pregnancies does not affect ovarian reserve in in vitro fertilization patients.
Moragianni VA
Fertil Steril; 2014 Feb; 101(2):337-8. PubMed ID: 24355052
[No Abstract] [Full Text] [Related]
4. Methotrexate for assisted reproductive technology (ART) ectopic pregnancy.
Hill MJ; Levens ED; Wolff EF
Fertil Steril; 2014 Feb; 101(2):e11. PubMed ID: 24485505
[No Abstract] [Full Text] [Related]
5. Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization-Embryo Transfer Outcomes.
Pereira N; Gerber D; Gerber RS; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
J Minim Invasive Gynecol; 2015; 22(5):870-6. PubMed ID: 25917279
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the long-term effects of single-dose methotrexate and salpingectomy on ovarian reserve in terms of anti-müllerian hormone levels.
Sahin Ersoy G; Turhan OT; Sakin O; Bulut S
Hum Fertil (Camb); 2016 Dec; 19(4):262-267. PubMed ID: 27483358
[TBL] [Abstract][Full Text] [Related]
7. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
[TBL] [Abstract][Full Text] [Related]
8. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?
Boots CE; Gustofson RL; Feinberg EC
Fertil Steril; 2013 Dec; 100(6):1590-3. PubMed ID: 24035728
[TBL] [Abstract][Full Text] [Related]
9. Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study.
Chen T; Zhao F; Wang Q; Liu C; Lan Y; Wang S; Xin Z; Yang X
J Ovarian Res; 2020 Jul; 13(1):80. PubMed ID: 32684158
[TBL] [Abstract][Full Text] [Related]
10. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.
Devine K; Mumford SL; Wu M; DeCherney AH; Hill MJ; Propst A
Fertil Steril; 2015 Sep; 104(3):612-19.e3. PubMed ID: 26049057
[TBL] [Abstract][Full Text] [Related]
11. Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy.
Uyar I; Yucel OU; Gezer C; Gulhan I; Karis B; Hanhan HM; Ozeren M
Fertil Steril; 2013 Nov; 100(5):1310-3. PubMed ID: 23891021
[TBL] [Abstract][Full Text] [Related]
12. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy.
Sahin C; Taylan E; Akdemir A; Ozgurel B; Taskıran D; Ergenoglu AM
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():150-2. PubMed ID: 27592417
[TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation.
McLaren JF; Burney RO; Milki AA; Westphal LM; Dahan MH; Lathi RB
Fertil Steril; 2009 Aug; 92(2):515-9. PubMed ID: 18829004
[TBL] [Abstract][Full Text] [Related]
14. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.
Kalra SK; Ratcliffe SJ; Dokras A
Fertil Steril; 2013 Jul; 100(1):208-13. PubMed ID: 23557762
[TBL] [Abstract][Full Text] [Related]
15. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
16. Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review.
Andersen ST; Pors SE; Poulsen LC; Colmorn LB; Macklon KT; Ernst E; Humaidan P; Andersen CY; Kristensen SG
Fertil Steril; 2019 Nov; 112(5):908-921. PubMed ID: 31594631
[TBL] [Abstract][Full Text] [Related]
17. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
[TBL] [Abstract][Full Text] [Related]
18. Follicle flushing does not improve live birth and increases procedure time: a systematic review and meta-analysis of randomized controlled trials.
Martini AE; Dunn A; Wells L; Rollene N; Saunders R; Healy MW; Terry N; DeCherney A; Hill MJ
Fertil Steril; 2021 Apr; 115(4):974-983. PubMed ID: 33676753
[TBL] [Abstract][Full Text] [Related]
19. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
[TBL] [Abstract][Full Text] [Related]
20. Impact of hypogonadotropic hypogonadism on ovarian reserve and response.
Cecchino GN; Canillas GM; Cruz M; García-Velasco JA
J Assist Reprod Genet; 2019 Nov; 36(11):2379-2384. PubMed ID: 31625035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
